Peer-influenced content. Sources you trust. No registration required. This is HCN.
Journal of the American College of Cardiology (JACC)
In patients with both cirrhosis and atrial fibrillation, apixaban initiation was associated with lower rates of major bleeding compared to rivaroxaban or warfarin, without compromising thromboembolic protection.
Cardiology August 5th 2024
Cleveland Clinic Journal of Medicine
Despite its theoretical benefits, IV albumin has not shown consistent superiority over crystalloid solutions in sepsis management, prompting a reevaluation of fluid resuscitation strategies in critical care settings.
Emergency Medicine July 16th 2024
The New England Journal of Medicine
In a recent study, 95% of ITP patients treated with the novel anti-CD38 monoclonal antibody, CM313, achieved two consecutive platelet counts of at least 50×10^9 per liter within just eight weeks, highlighting the therapy’s efficacy and rapid action.
Hematology July 1st 2024
Red-cell rosette formation in malaria may allow infected erythrocytes to evade splenic sequestration, posing challenges in treatment.
Hematology June 4th 2024
Medical News Today (MNT)
An AI-powered test using dried blood spots can diagnose pancreatic, gastric, and colorectal cancers in minutes with 82–100% sensitivity, offering a cost-effective alternative for low-income regions.
Hematology May 28th 2024
The study found that andexanet alfa significantly improves hemostatic efficacy in patients with intracerebral hemorrhage on factor Xa inhibitors but increases the risk of thrombotic events. These findings highlight the need for careful patient selection and monitoring when considering andexanet alfa in clinical practice.
Hematology May 20th 2024